![Bonnie J. Stearns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Bonnie J.
Stearns worked as a Director of Clinical Development at Cytyc Corp.
from 1999 to 2002.
She then worked as the VP of European Operations and Clinical Affairs at Broncus Technologies, Inc. from 2002 to 2013.
Stearns received an undergraduate degree from California State University-Los Angeles.
Former positions of Bonnie J. Stearns
Companies | Position | End |
---|---|---|
Broncus Technologies, Inc.
![]() Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Chief Tech/Sci/R&D Officer | 2013-01-31 |
Cytyc Corp.
![]() Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Corporate Officer/Principal | 2002-08-31 |
Training of Bonnie J. Stearns
California State University-Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Broncus Technologies, Inc.
![]() Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Health Technology |
Cytyc Corp.
![]() Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Bonnie J. Stearns